Title:Commentary on “Peptide-Conjugated Nanoparticles as Targeted Anti-angiogenesis Therapeutic and Diagnostic in Cancer” by Shaker A. Mousa, Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, United States - Peptide-Conjugated Nanoparticles for Multimodal Nanomedicine
Volume: 27
Issue: 17
Author(s): Ajay Vikram Singh*
Affiliation:
- Department of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR) Max- Dohrn-Strasse 8-10, 10589, Berlin,Germany